Delivery Order SPE2DB20D3103-SPE2DB25FQ0N9
- Not listed
- The Defense Logistics Agency (DLA) awarded a $12,636.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on August 29, 2025, with a completion date of September 2, 2025. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Zepbound 10 mg/0.5 mL pens with a ceiling value of $2,890.34. This is a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award is non-competitive and represents a single delivery order under the company's larger indefinite delivery contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $13,836.67 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Zepbound 10 mg/0.5 mL pens valued at $7,637.15 with a completion date of June 18, 2025. This non-competitive delivery order utilizes firm fixed price pricing and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,785.41 on June 17, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This non-competitive, firm fixed-price delivery order is expected to be completed by June 18, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with the DLA. This delivery order is issued under...
- The Defense Logistics Agency awarded a $35,787.10 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Zepbound 10 mg/0.5 ml pens. The contract represents a firm fixed price, competitively awarded delivery order with a completion date of August 20, 2025, and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order carries no set-aside designation, indicating open competition among qualified vendors. This...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $31,043.40 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 8, 2025. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 12.5 mg/0.5 ml pens valued at $7,543.07 on July 18, 2025, with completion targeted for July 21, 2025. This firm fixed-price delivery order, which received no set-aside designation, will be performed at AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction within the company's existing indefinite delivery vehicle with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $3,812.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 7, 2025. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, is scheduled for completion by August 8, 2025, with the place of performance in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader contract vehicle with the Defense Logistics...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a firm fixed price delivery order valued at $17,749.40 for Zepbound 2.5 mg/0.5 ml pens with a completion date of July 14, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply vehicle with DLA. The product will be performed at the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ0N9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on August 27, 2025, with a contract ceiling value of $17,992.06 and an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is to be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the Defense Logistics Agency. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp supplies critical medical products to support military and veteran healthcare systems. The Zepbound delivery fulfills the federal government's pharmaceutical procurement needs within the broader context of the DLA's medical supply chain operations, which distribute a wide spectrum of medications and medical supplies across multiple therapeutic domains to Defense Health Agency customers, the U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.0k | 8/27/25 |